ID: ALA2398663

Max Phase: Preclinical

Molecular Formula: C13H8FNO2

Molecular Weight: 229.21

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N#Cc1ccc(Oc2ccccc2O)c(F)c1

Standard InChI:  InChI=1S/C13H8FNO2/c14-10-7-9(8-15)5-6-12(10)17-13-4-2-1-3-11(13)16/h1-7,16H

Standard InChI Key:  OCEOHJLRTQYDSB-UHFFFAOYSA-N

Associated Targets(non-human)

Enoyl-[acyl-carrier-protein] reductase [NADH] 33 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 229.21Molecular Weight (Monoisotopic): 229.0539AlogP: 3.20#Rotatable Bonds: 2
Polar Surface Area: 53.25Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.15CX Basic pKa: CX LogP: 3.17CX LogD: 3.10
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.86Np Likeness Score: -1.04

References

1. Hu X, Compton JR, Abdulhameed MD, Marchand CL, Robertson KL, Leary DH, Jadhav A, Hershfield JR, Wallqvist A, Friedlander AM, Legler PM..  (2013)  3-substituted indole inhibitors against Francisella tularensis FabI identified by structure-based virtual screening.,  56  (13): [PMID:23815100] [10.1021/jm4001242]

Source